IRF2BP2 and acute lymphoblastic leukemia: Knockdown of BRD4 in T‐ALL cell lines Jurkat and J.gamma1 resulted in a significant decrease in IRF2BP2 expression at both the protein and mRNA levels (Figure 1D,E).